Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… EVOXAC (cevimeline HCl) Capsules, 30 mg, SnowBrand NDA 20-989 1/11/00 1/19/00 1/19/00 3/12/02 EVOXAC Indication: for the treatment of symptoms of dry mouth in patients with Sjogren's Syndrome. | EVOXAC (cevimeline HCl) Capsules, Daiichi Pharma, Labeling Revision | EVOXAC (cevimeline HCl) Capsules, Daiichi-Sankyo Pharma, Labeling Revision | Cevimeline Hydrochloride Capsules, Roxane Laboratories, Inc., Tentative Approval | Cevimeline Hydrochloride Capsules, Apotex Corp., Approval View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com